HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

9- (2- (phosphonomethoxy)ethyl)- N(6)- (2- dimethylaminoethyl)- 2,6- diaminopurine

Also Known As:

Me(2)NEt-PMEDAP; Me2NEt-PMEDAP

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Adenine: 2120
        9-(2-(phosphonomethoxy)ethyl)-N(6)-(2-dimethylaminoethyl)-2,6-diaminopurine: 2
Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - 9-(2-(phosphonomethoxy)ethyl)-N(6)-(2-dimethylaminoethyl)-2,6-diaminopurine: 2

Experts

1.	Bílá, Vlasta: 1 article (11/2003)
2.	Eckschlager, Tomás: 1 article (11/2003)
3.	Hanzalová, Jitka: 1 article (11/2003)
4.	Holý, Antonín: 1 article (11/2003)
5.	Krejcí, Ondrej: 1 article (11/2003)
6.	Otová, Berta: 1 article (11/2003)
7.	Trka, Jan: 1 article (11/2003)
8.	Valeriánová, Marie: 1 article (11/2003)
9.	Votruba, Ivan: 1 article (11/2003)
10.	Holy, A: 1 article (05/2001)

Related Diseases

1.	Neoplasms (Cancer) 05/01/2001 - "The antitumour activity of four N6-substituted PMEDAP derivatives, Me2NEt-PMEDAP, allyl-PMEDAP, Me2-PMEDAP and cypr-PMEDAP, selected on the basis of their in vitro cytostatic activity, was studied in an in vivo model of haematological malignancy of inbred Sprague-Dawley rats. "
2.	Chromosome Aberrations (Chromosome Abnormalities) 11/01/2003 - "Genotoxic properties expressed as acquired chromosomal aberrations and induction of apoptosis after treatment with acyclic nucleoside phosphonates PMEG, PMEDAP and its N6-substituted derivatives Me2NEt-PMEDAP, allyl-PMEDAP, Me2-PMEDAP and cypr-PMEDAP, were studied in in vitro conditions. "

Related Drugs and Biologics

1.	9- (2- (phosphonomethoxy)ethyl)- N(6)- allyl- 2,6- diaminopurine
2.	9- (2- (phosphonomethoxy)ethyl)- N(6)- dimethyl- 2,6- diaminopurine
3.	9- (2- phosphonylmethoxyethyl)- 2,6- diaminopurine
4.	Organophosphonates (Phosphonates)
5.	Cytostatic Agents
6.	Nucleosides
7.	9-((2-phosphonylmethoxy)ethyl)guanine

Related Therapies and Procedures

1.	Aftercare (After-Treatment)